Thomas Scoot Johnston
No más puestos en curso
Historial de carrera de Thomas Scoot Johnston
Antiguos cargos conocidos de Thomas Scoot Johnston.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Mucosis BV
 Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Director Ejecutivo | 20/09/2012 | - |
| Corporate Officer/Principal | 01/05/2011 | 20/09/2012 | |
| COMCAST CORPORATION | Corporate Officer/Principal | - | - |
| NOVAVAX, INC. | Corporate Officer/Principal | 19/06/2009 | - |
| SCHLUMBERGER AG | Corporate Officer/Principal | - | - |
| MICROSOFT CORPORATION | Corporate Officer/Principal | - | - |
Formación de Thomas Scoot Johnston.
| Arcadia University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Austria | 2 |
| Países Bajos | 2 |
Operativa
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Consumer Services | 4 |
| Technology Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MICROSOFT CORPORATION | Technology Services |
| NOVAVAX, INC. | Health Technology |
| COMCAST CORPORATION | Consumer Services |
| Empresas privadas | 2 |
|---|---|
Schlumberger GmbH /Austria/
 Schlumberger GmbH /Austria/ Beverages: AlcoholicConsumer Non-Durables Schlumberger AG operates as a holding company, which engages in the production, sale, and distribution of alcoholic and non-alcoholic beverages. The firm offers wine, sparkling wine, champagne, and spirituous beverages. It distributes its products under the Gurktaler Alpenkräuter, Rossbacher, Underberg, Asbach, Bols, Metaxa, Leibwächter, Nonino, Stock, Remy Martin, Stolichnaya, XUXU, evian, Volvic, Badoit, Riemerschmid, and SENS brands. The company was founded by Robert Alwin Schlumberger in 1842 and is headquartered in Vienna, Austria. | Consumer Non-Durables |
Mucosis BV
Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Commercial Services |
